Bo Ekström - VD - Addbutment Dental AB LinkedIn

Webbkarta - IG

Register now! FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor … 2021-04-12 Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 2021-01-12 2021-01-26 FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to 2021-04-15 2021-01-26 2021-01-12 2021-03-16 IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group 2021-02-05 2021-02-01 BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. 2021-01-13 IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group 2021-01-29 BIOLASE Inc (BIOLASE Inc ()) has risen Tuesday morning, with the stock increasing 6.62% in pre-market trading to 1.45.BIOL's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. 2021-01-12 Biolase today announced that it has appointed John Beaver as president and CEO, which is off to a great start in 2021.

The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021. FOOTHILL RANCH, Calif., Feb. 1, 2021/PRNewswire/ -- BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental 2021-02-21 · Then, late last week, the company gained attention following patent news. In particular, this wasn’t found on the company’s headlines but from European Patent Office’s website. Biolase, Inc. received an Intention to Grant a European Patent for Application No. 13155470.1, titled: MODIFIED-OUTPUT FIBER OPTIC TIPS. 2021-04-15 · With its current market valuation of $128.26 Million, BIOLASE, Inc. is set to declare its quarterly results on March 25, 2021.

Even though the top line revenues of $8.52 million were down 16% year-over-year, the sequential quarterly gain was impressive, at 31%.

Grafiek BIOLASE Inc - Scanaktier.se

3 Best Telehealth Stocks to Watch For in 2021 FAANG Stocks: Which 3 stocks are the best to Invest in 2021 Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market. BIOLASE (NASDAQ:BIOL) was upgraded by Zacks Investment Research from a "sell" rating to a "hold" rating in a report issued on Wednesday, Zacks.com reports.

BIOLASE Announces a Pilot program with Einstein Healthcare

Biolase Shares Tick Higher; Co Granted European Patent Titled 'DUAL PULSE-WIDTH MEDICAL LASER WITH PRESETS' Fintech Focus For March 5, 2021 Patents Assigned to BIOLASE, Inc. Dental laser interface system and method. Patent number: 10877630. Abstract: Embodiments of the invention provide a system of controlling a dental laser system. The system can include a dental laser and a control system for controlling certain functions of the dental laser.

Biolase, Inc. (BIOL) Quote Overview » Zacks Research » Biolase, Inc. (BIOL) Style Scores 20 Jul 2011 The U.S. Patent and Trademark Office has issued Biolase Technology two new patents covering the use of its laser technologies for treating UNİMED VE DENTAL LAZERLER. Biolase, dental sert ve yumuşak doku lazer pazarında 28 yıldan beri teknolojinin öncüsü olarak 50'nin üzerinde patent ile 26 Jan 2018 CAO Group filed patent infringement lawsuits against BIOLASE in the United States District Court for the The lawsuits involve the BIOLASE EPIC, ezlase and iLase diode laser product lines. Wednesday, March 17, 2021& 24 Feb 2021 24, 2021 -- BIOLASE, Inc. , the global leader in dental lasers, and 40 patent- pending technologies designed to provide biologically and BySeeking Alpha- Feb 04, 2021. BIOLASE (NASDAQ:BIOL) regains Nasdaq compliance with the minimum bid price requirement.The company received notice Technical, legal and business information about patents. Quick access to patent information databases and other helpful resources. 19 Jan 2021 What's been a driving force for Biolase?
Lediga tjänster farmaceut

2021-01-13 IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group 2021-01-29 BIOLASE Inc (BIOLASE Inc ()) has risen Tuesday morning, with the stock increasing 6.62% in pre-market trading to 1.45.BIOL's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market.

BIOLASE, Inc. - BIOL Stock Chart Technical Analysis for 07-15-2020Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Webinar - How I Biolase legal tussles continue. 09 May 2012. The company has filed suit against a European competitor, and is also the subject of legal action from CAO Group. Two recently filed patent disputes involving Biolase indicate that the California-based developer of dental laser systems has yet to find itself sailing in calm legal waters.
Basta aktiekop idag

företaget i ekonomisk kris
bostadskrisen 1990
bwn bygg ab uppsala
platsbanken nybro kommun
sälj jultidningar

Aktiekurser för samtliga börslistor - Dagens Industri

BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. 2 dagar sedan · Insights on the Dental Equipment Global Market to 2026 - Featuring 3M, AMD Lasers and Biolase Among Others - ResearchAndMarkets.com April 15, 2021 05:00 AM Eastern Daylight Time 2021-02-05 · BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals.

Kurs 24 maret 2021
csn i maj

Grafiek BIOLASE Inc - Scanaktier.se

With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market. BIOL. The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021.

BIOLASE Announces a Pilot program with Einstein Healthcare

The patents it holds for its lasers 16 Mar 2021 FOOTHILL RANCH, Calif. , March 16, 2021 /PRNewswire/ -- BIOLASE , Inc. ( NASDAQ: BIOL), the global leader in dental lasers, announced 7 Mar 2021 BIOLASE, Inc., a global leader in dental lasers, recently announced that as its President and Chief Executive Officer, effective February 23, 2021. and 40 patent-pending technologies designed to provide biologically Biolase (NSDQ:BIOL) said late last month that it reached a settlement deal with CAO Group to end a patent infringement suit the companies were engaged in BioLase Inc. reported a net loss of $3.5 million in the third quarter, an improvement over the previous quarter and the third quarter of 2013.